Osterro® exists to support individuals navigating the growing concern of bone loss associated with GLP-1 medications.

 

​Our advanced formulation was developed around clinically studied ingredients selected for their role in supporting bone mineral density, collagen structure, calcium utilization, and skeletal integrity.

 

Over the last several years, emerging research has continued to highlight the importance of maintaining bone health during rapid weight loss and metabolic change associated with GLP-1 therapies.

​

Osterro® was carefully structured to support comprehensive skeletal health rather than relying on basic calcium supplementation alone.

​

The formulation was designed over multiple iterations to ensure the following:

​

• Each ingredient was selected based on clinical relevance to bone health

• Ingredient combinations were reviewed for absorption and compatibility

• Bone matrix, mineral density, and collagen support were all considered

• Dosages and ingredient forms were optimized for consistency and effectiveness

​

Osterro® isn’t just another bone supplement—it’s a targeted formulation built specifically for the modern GLP-1 era.